These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
294 related articles for article (PubMed ID: 20037580)
21. Bat adeno-associated viruses as gene therapy vectors with the potential to evade human neutralizing antibodies. Li Y; Li J; Liu Y; Shi Z; Liu H; Wei Y; Yang L Gene Ther; 2019 Jun; 26(6):264-276. PubMed ID: 31110296 [TBL] [Abstract][Full Text] [Related]
22. Characterization of tissue tropism determinants of adeno-associated virus type 1. Hauck B; Xiao W J Virol; 2003 Feb; 77(4):2768-74. PubMed ID: 12552020 [TBL] [Abstract][Full Text] [Related]
23. Creation of a cardiotropic adeno-associated virus: the story of viral directed evolution. Yang L; Xiao X Virol J; 2013 Feb; 10():50. PubMed ID: 23394344 [TBL] [Abstract][Full Text] [Related]
24. Assessment of AAV Vector Tropisms for Mouse and Human Pluripotent Stem Cell-Derived RPE and Photoreceptor Cells. Gonzalez-Cordero A; Goh D; Kruczek K; Naeem A; Fernando M; Kleine Holthaus SM; Takaaki M; Blackford SJI; Kloc M; Agundez L; Sampson RD; Borooah S; Ovando-Roche P; Mehat MS; West EL; Smith AJ; Pearson RA; Ali RR Hum Gene Ther; 2018 Oct; 29(10):1124-1139. PubMed ID: 29580100 [TBL] [Abstract][Full Text] [Related]
25. Gene transfer into skeletal muscle using novel AAV serotypes. Louboutin JP; Wang L; Wilson JM J Gene Med; 2005 Apr; 7(4):442-51. PubMed ID: 15517544 [TBL] [Abstract][Full Text] [Related]
26. Effect of adeno-associated virus serotype and genomic structure on liver transduction and biodistribution in mice of both genders. Pañeda A; Vanrell L; Mauleon I; Crettaz JS; Berraondo P; Timmermans EJ; Beattie SG; Twisk J; van Deventer S; Prieto J; Fontanellas A; Rodriguez-Pena MS; Gonzalez-Aseguinolaza G Hum Gene Ther; 2009 Aug; 20(8):908-17. PubMed ID: 19419275 [TBL] [Abstract][Full Text] [Related]
27. Engineering liver-detargeted AAV9 vectors for cardiac and musculoskeletal gene transfer. Pulicherla N; Shen S; Yadav S; Debbink K; Govindasamy L; Agbandje-McKenna M; Asokan A Mol Ther; 2011 Jun; 19(6):1070-8. PubMed ID: 21364538 [TBL] [Abstract][Full Text] [Related]
28. Adeno-associated viral vectors and their redirection to cell-type specific receptors. Michelfelder S; Trepel M Adv Genet; 2009; 67():29-60. PubMed ID: 19914449 [TBL] [Abstract][Full Text] [Related]
29. Designer gene delivery vectors: molecular engineering and evolution of adeno-associated viral vectors for enhanced gene transfer. Kwon I; Schaffer DV Pharm Res; 2008 Mar; 25(3):489-99. PubMed ID: 17763830 [TBL] [Abstract][Full Text] [Related]
30. In Search of Adeno-Associated Virus Vectors With Enhanced Cardiac Tropism for Gene Therapy. Sasaki N; Kok CY; Westhaus A; Alexander IE; Lisowski L; Kizana E Heart Lung Circ; 2023 Jul; 32(7):816-824. PubMed ID: 37451880 [TBL] [Abstract][Full Text] [Related]
31. In vitro and in vivo gene therapy vector evolution via multispecies interbreeding and retargeting of adeno-associated viruses. Grimm D; Lee JS; Wang L; Desai T; Akache B; Storm TA; Kay MA J Virol; 2008 Jun; 82(12):5887-911. PubMed ID: 18400866 [TBL] [Abstract][Full Text] [Related]
32. Hepatocyte Heparan Sulfate Is Required for Adeno-Associated Virus 2 but Dispensable for Adenovirus 5 Liver Transduction In Vivo. Zaiss AK; Foley EM; Lawrence R; Schneider LS; Hoveida H; Secrest P; Catapang AB; Yamaguchi Y; Alemany R; Shayakhmetov DM; Esko JD; Herschman HR J Virol; 2016 Jan; 90(1):412-20. PubMed ID: 26491162 [TBL] [Abstract][Full Text] [Related]
33. Engineering and selection of shuffled AAV genomes: a new strategy for producing targeted biological nanoparticles. Li W; Asokan A; Wu Z; Van Dyke T; DiPrimio N; Johnson JS; Govindaswamy L; Agbandje-McKenna M; Leichtle S; Redmond DE; McCown TJ; Petermann KB; Sharpless NE; Samulski RJ Mol Ther; 2008 Jul; 16(7):1252-60. PubMed ID: 18500254 [TBL] [Abstract][Full Text] [Related]
34. Naturally occurring singleton residues in AAV capsid impact vector performance and illustrate structural constraints. Vandenberghe LH; Breous E; Nam HJ; Gao G; Xiao R; Sandhu A; Johnston J; Debyser Z; Agbandje-McKenna M; Wilson JM Gene Ther; 2009 Dec; 16(12):1416-28. PubMed ID: 19727141 [TBL] [Abstract][Full Text] [Related]
35. Comparative antiatherogenic effects of intravenous AAV8- and AAV2-mediated ApoA-IMilano gene transfer in hypercholesterolemic mice. Tian F; Wang L; Arias A; Yang M; Sharifi BG; Shah PK J Cardiovasc Pharmacol Ther; 2015 Jan; 20(1):66-75. PubMed ID: 24742767 [TBL] [Abstract][Full Text] [Related]
36. Focused ultrasound as a novel strategy for noninvasive gene delivery to retinal Müller glia. Touahri Y; Dixit R; Kofoed RH; Miloska K; Park E; Raeisossadati R; Markham-Coultes K; David LA; Rijal H; Zhao J; Lynch M; Hynynen K; Aubert I; Schuurmans C Theranostics; 2020; 10(7):2982-2999. PubMed ID: 32194850 [TBL] [Abstract][Full Text] [Related]
37. Insertional mutagenesis at positions 520 and 584 of adeno-associated virus type 2 (AAV2) capsid gene and generation of AAV2 vectors with eliminated heparin- binding ability and introduced novel tropism. Shi X; Fang G; Shi W; Bartlett JS Hum Gene Ther; 2006 Mar; 17(3):353-61. PubMed ID: 16544984 [TBL] [Abstract][Full Text] [Related]
38. Infectivity of adeno-associated virus serotypes in mouse testis. Rajasekaran S; Thatte J; Periasamy J; Javali A; Jayaram M; Sen D; Krishnagopal A; Jayandharan GR; Sambasivan R BMC Biotechnol; 2018 Nov; 18(1):70. PubMed ID: 30384832 [TBL] [Abstract][Full Text] [Related]
39. Restoring the natural tropism of AAV2 vectors for human liver. Cabanes-Creus M; Hallwirth CV; Westhaus A; Ng BH; Liao SHY; Zhu E; Navarro RG; Baltazar G; Drouyer M; Scott S; Logan GJ; Santilli G; Bennett A; Ginn SL; McCaughan G; Thrasher AJ; Agbandje-McKenna M; Alexander IE; Lisowski L Sci Transl Med; 2020 Sep; 12(560):. PubMed ID: 32908003 [TBL] [Abstract][Full Text] [Related]